Hot Warren Buffett Stocks For 2017


Warren Buffett has remained quiet, despite being the largest Wells Fargo (NYSE:WFC) shareholder. Why so quiet? I feel he likely doesn’t agree with WFC’s practices (or doesn’t care), but what’s he really to do? He can’t sell, and buying isn’t a sound idea – this isn’t a generational buying opportunity for WFC.

Click to enlarge

Buffett won’t be riding to the rescue of anything soon, but there’s only a handful of companies with large enough market caps that he can invest in these days. At the same time, Buffett has been taken to task in the past over his ethical decisions (read: a large investment in sugary drink maker Coca-Cola (NYSE:KO), his trailer park business, the Sokol-Lubrizol days, etc.)

Hot Warren Buffett Stocks For 2017: Genie Energy Ltd.(GNE)


Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, utilities shares fell by 0.75 percent. Meanwhile, top losers in the sector included Genie Energy Ltd (NYSE: GNE), down 5 percent, and Consolidated Water Co. Ltd. (NASDAQ: CWCO), down 2 percent.

  • [By Lisa Levin]

    In trading on Tuesday, utilities shares fell by 0.58 percent. Meanwhile, top losers in the sector included Middlesex Water Company (NASDAQ: MSEX), down 2 percent, and Genie Energy Ltd (NYSE: GNE), down 4 percent.

Hot Warren Buffett Stocks For 2017: Coherus BioSciences, Inc.(CHRS)


Advisors’ Opinion:

  • [By Ben Levisohn]

    Today,Coherus BioSciences (CHRS) lost a patent case with AbbVie (ABBV) that would have allowed for a generic version of Humira. Citigroup’s Andrew Baum and Peter Verdult have the details:

    Agence France-Presse/Getty Images

    The Patent Trial and Appeal Boardjust announced that CHRSs IPR on the 166 Humira formulation patent was not instituted. We remind investors that Amgens IPR on the same 157 and 158 formulation patents were also not instituted. Any at risk launch on a formulation that potentially infringes 166, 157 or 158 would seem unlikely and carries a high risk thatAbbVie would attain a preliminary injunction. It is not clear whether either company could attempt launch with a formulation that does not infringe the patent estate. We note that Sandoz has uniquely not filed any IPR on any biosimilars. Sandoz has not announced the FDA has accepted their filing for their biosimilar adalimumab…We anticipate that the perceived historic relationship of the immunogenicity of Humira as it relates to dose stretching will form a key debate in the ongoing PTAB case…


    Following the decision of the PTAB not to institute CHRS IPR on the 166 Humira formulation patent, we continue to anticipate that first likely launch of biosimilar adalimumab (Humira) in the US will be delayed until 2020, in line with our published forecasts and biosimilar model. We anticipate the open IPR hearings for the 135 dosing patent on Humira (filed by Boehringer and Coherus) to begin in Feb 2017 with the ruling in May. We rateAbbVie a Buy. We continue to prefer BUY rated Bristol-Myers Squibb (BMY), Eli Lilly (LLY) among the US names.

    Shares of AbbVie have climbed 5.6% to $59.18 at 3:05 p.m. today, while Coherus BioSciences has tumbled 11% to $25.18,Bristol-Myers Squibb has gained 3% to $52.56, andEli Lilly has risen 1.7% to $73.70.

Hot Warren Buffett Stocks For 2017: Clayton Williams Energy, Inc.(CWEI)


Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Clayton Williams Energy, Inc. (NYSE: CWEI) got a boost, shooting up 28 percent to $94.93 after the company announced an agreement to sell Giddings Area assets for $400 million and named Patrick Cooke as COO.

  • [By Dustin Parrett]

    Company Name

    Share PriceYTDMarket CapClayton Williams Energy Inc. (NYSE: CWEI)$138.8216.4%2.4BDiamondback Energy Inc. (Nasdaq: FANG)$106.365.42%$9.38BWestern Gas Partners LP (NYSE: WES)$65.6411.71%$9.67BTesoro Logistics LP (NYSE: TLLP)$59.3416.79%$6.25BResolute Energy Corp. (NYSE: REN)$46.0811.87%$931.13MAntero Midstream Partners LP (NYSE: AM)$34.9813.28%$6.4BExterran Corp. (NYSE: EXTN)$33.9942.22%$1.19BDominion Midstream Partners LP (NYSE: DM)$32.9011.34%$2.6BNextEra Energy Partners LP (NYSE: NEP)$31.1922.12%$1.68BArchrock Inc. (NYSE: AROC)$16.0021.21%$1.12B


    While some of these stocks have performed well, we arent recommending this list of natural gas stocks. Thats because we arent interested in stocks that have already peaked at Money Morning; were interested in the next big winner. And we have one that could surge in 2017

  • [By Ben Levisohn]

    Noble Energy (NBL) soared to the top of the S&P 500 today after purchasing Clayton Williams Energy (CWEI) for $2.7 billion.

    Agence France-Presse/Getty Images

    Noble Energygained 7.1% to $40.05, while the S&P 500 fell 0.3% to2,267.89.

  • [By Andrew Efimoff]

    WTI crude oil plunged 3.11 percent on Friday to $48.99 a barrel. Below are the biggest energy losers for the day:

    California Resources Corporation (NYSE: CRC): -19.22% Dynamic Materials (NASDAQ: BOOM): -12.39% Clayton Williams Energy (NYSE: CWEI): -11.45% Dynergy (NYSE: DYN): -11.91% EP Energy Corporation (NYSE: EPE): -11.20% Mexco Energy (NYSE: MXC) -10.90% Whiting Petroleum (NYSE: WLL) -10.79% Southwestern Energy Company (NYSE: SWN) -10.79% SM Energy Company (NYSE: SM) -10.38% Real Goods Solar (NASDAQ: RGSE) -10.34%


    Posted-In: Commodities After-Hours Center Markets Movers

Hot Warren Buffett Stocks For 2017: Tantech Holdings Ltd.(TANH)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Friday, our Under the Radar Moversnewsletter suggestedshorting small cap China based carbon stock Tantech Holdings Ltd (NASDAQ: TANH):

    “The downtrend here is crystal clear; more of the same weakness is there on the earlier part of the chart you can’t see. What’s so compelling about the selloff is yesterday’s bar. The bulls tried to bounce back, but couldn’t… the buyers threw in the towel. TANH peeled back to close closer to the low than the high, and is following through — to the downside — today.”

Hot Warren Buffett Stocks For 2017: Match Group, Inc.(MTCH)

Advisors’ Opinion:

  • [By Jeremy Bowman]

    In its first full year as a publicly traded company, online dating conglomerateMatch Group (NASDAQ:MTCH) surged past expectations, climbing 26%.

    A number of factors led to its standout performance, including blockbuster growth from Tinder, strong operating leverage, and consistently beaten earnings estimates. Let’s take a closer look at how things played out in 2016.

Leave a Reply

Your email address will not be published. Required fields are marked *